Loading...

Loading...

Advancing healthcare interoperability challenges
By Mónica López - Wed, 02/17/2021 - 11:01
In an increasingly digitized world, more and more data is generated every day. In the healthcare sector, this represents a huge opportunity
https://mexicobusiness.news/tag/mhs-202021-video
More Health
Running Against the Clock: Developing a COVID-19 Vaccine
By Mónica López - Tue, 02/16/2021 - 18:43
Treatment and vaccine developing leaders share their experience on delivering a solution to the COVID-19 pandemic.
Telemedicine to Increase Healthcare Access: The Impact of COVID19
By Mónica López - Tue, 02/16/2021 - 18:34
Challenges for telemedicine are still many and the entire industry will have to face them for this model to grow its penetration
International Perspectives of COVID-19
By Mónica López - Tue, 02/16/2021 - 14:46
UK Ambassador to Mexico Corin Robertson detailed how this pandemic has demonstrated the importance of exchanging knowledge at a global level.
Technology Enhancing Patient Care
By Mónica López - Tue, 02/16/2021 - 14:39
How can technology improve healthcare provision without replacing human talent?
Pharmacy-Adjacent Medical Offices: Solution to Increase Access
By Mónica López - Tue, 02/16/2021 - 14:31
What benefits can pharmacy-adjacent clinics bring to the Mexican population?
Developing a COVID-19 Diagnosis Test – Biomérieux
By Mónica López - Tue, 02/16/2021 - 14:27
Among the most common medical errors today are hospital infections, mistakes while filling a prescription and late or erroneous diagnoses
Out-of-Pocket Expenditure vs COVID-19
By Mónica López - Tue, 02/16/2021 - 14:20
How the pandemic could be a source of new ingenuity in insurance schemes.
The Impact of the Pandemic on Diabetic Patients
By Mónica López - Tue, 02/16/2021 - 14:14
Diabetes remains one of the most costly diseases in Mexico and the problem will only increase as the population in Mexico grows older and older
Cannabis: Window of Opportunities
By Mónica López - Tue, 02/16/2021 - 14:09
Participants reflect on the meaning of the recently passed legislation for pharmaceutical products derived from cannabis.